Where and How DCTs Can Truly Enable and Close the Gaps between Research and Care

In this session, panelists from pharma and healthcare share perspectives on innovations in decentralized clinical trial technologies that have and have not worked during and throughout COVID. They also discuss:

• How we are bringing forth trial options to people on their own terms and getting patient input
• Creating flexible systems that don’t increase undue burden on hospitals and sites
• What hasn’t worked and why
• Managing cost and spend

Speakers:

• Sharon Hanlon, Head, Clinical Trial Engagement & Enrolment, Bristol Myers Squibb
• Christina Brennan, MD, MBA, VP, Clinical Research, Northwell Health
• Jamie Harper, MHA, CCRP, Director, Site Engagement & Relations, WCG Clinical
• Ramita Tandon, Chief Clinical Trials Officer, Walgreens Health, Walgreens Boots Alliance
• Susan Wong, PA, Principal Quality & Compliance Manager, gRED, Genentech